HR 3288 — Access to Prescription Digital Therapeutics Act of 2025
Congress 119 · introduced 2025-05-08
Latest action: — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
- Hern, Kevin (R, OK-1) — sponsor · 2025-05-08
Lobbied by (1)
LDA filings that named this bill in their activity descriptions. The lobbying firm (registrant) is paid by the client to lobby on this and related issues.
| Filing | Period | Registrant (lobbying firm) | Client | Income | Matched |
|---|---|---|---|---|---|
| 1st Quarter - Report | 2026 first_quarter | TIBER CREEK GROUP | ACADEMY OF MANAGED CARE PHARMACY | $80,000 | H.R. 3288 |
Action timeline
- · H11100 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- · H11100 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- · Intro-H — Introduced in House
- · 1000 — Introduced in House
Text versions
- Introduced in House · 2025-05-08 — open
Connected on the graph
Inbound (2)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | ACADEMY OF MANAGED CARE PHARMACY | lobbies_on_bill | — | H.R. 3288 | lobbying_bill_mention |
| 2025-05-08 | Hern, Kevin | sponsor_of_bill | — | sponsor | sponsorship |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Hern, Kevin (R, house OK-1) | sponsor | 0 | — | 5 |
Who's influencing them
Orgs ranked by combined money flow on this bill: LDA filings citing the bill + individual contributions in cycle 2026from donors whose employer matches the org name (Schedule A) to any principal committee in the "who matters" list above.
| # | Org | LDA filings | LDA spend | Donor employees | Employee donations | Total |
|---|---|---|---|---|---|---|
| 1 | ACADEMY OF MANAGED CARE PHARMACY | 1 | $80,000 | 0 | $0 | $80,000 |
| 2 | canada life re : for the acli ceo even | 0 | $0 | 1 | $1,250 | $1,250 |
| 3 | canada life reinsurance company | 0 | $0 | 1 | $1,250 | $1,250 |
| 4 | pcma | 0 | $0 | 1 | $275 | $275 |
| 5 | bama | 0 | $0 | 1 | $100 | $100 |
| 6 | retired | 0 | $0 | 2 | $10 | $10 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
1 predicted yes (0%) · 266 predicted no (49%) · 276 unknown (51%)
By party: · R: 1 yes / 0 no / 276 unknown · D: 0 yes / 263 no · I: 0 yes / 3 no
1 high-confidence positions (voted + sponsor + cosponsor)
- Hern, Kevin (R · house · OK-1) · sponsor
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-01-01 · lobbied on by ACADEMY OF MANAGED CARE PHARMACY (h.r. 3288) · lobbying_bill_mention
- 2025-05-08 · sponsored by Hern, Kevin (sponsor) · sponsorship